← Back to Search

Immunomodulator

VE800 combination treatment with nivolumab for Melanoma (ConsortiumIO Trial)

Phase 1 & 2
Waitlist Available
Led By Judy Wang, MD
Research Sponsored by Vedanta Biosciences, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights

ConsortiumIO Trial Summary

This trial will study if adding VE800 to the drug nivolumab could help treat patients with certain types of advanced cancer.

Eligible Conditions
  • Cancer
  • Melanoma
  • Stomach Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Colorectal Cancer

ConsortiumIO Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to two years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to two years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Objective Response Rate (ORR)
Safety and Tolerability of VE800 in Combination With Nivolumab: Number of Participants With Adverse Events
Secondary outcome measures
Best Overall Response
Degree of VE800 Bacterial Strain Colonization in Stool
Detection of VE800 Bacterial Strain Colonization in Stool
+5 more

ConsortiumIO Trial Design

1Treatment groups
Experimental Treatment
Group I: VE800 combination treatment with nivolumabExperimental Treatment3 Interventions
Subjects received 5 days of oral vancomycin, followed by daily VE800 in combination with nivolumab every 4 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
VE800
2020
Completed Phase 2
~60
Nivolumab
FDA approved
Vancomycin
FDA approved

Find a Location

Who is running the clinical trial?

Vedanta Biosciences, Inc.Lead Sponsor
6 Previous Clinical Trials
1,148 Total Patients Enrolled
Bristol-Myers SquibbIndustry Sponsor
2,639 Previous Clinical Trials
4,128,976 Total Patients Enrolled
177 Trials studying Melanoma
57,487 Patients Enrolled for Melanoma
Judy Wang, MDPrincipal InvestigatorSCRI - Florida Cancer Specialists - Sarasota Cattlemen Office (Coordinating Investigator)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
2020. "Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04208958.
~11 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top